DOTA Conjugated JM#21 derivative 7
This research compound, Ligand-7, is a DOTA-conjugated CXCR4-targeting peptide derivative. When radiolabeled with 177Lu, it forms a targeted radioligand with high tumor specificity and low non-target organ uptake in biodistribution studies, making it suitable for oncology and molecular imaging research.
Product Specifications
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery
Molecular Weight
1471.75
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP42085_P050-FITC 100 µL
SERPINB4 Antibody - N-terminal region : FITC (ARP42085_P050-FITC)
Sign In for Pricing
View Details GTR15317602 1 Vial
Lentiviral human C5orf46 shRNA (UAS) - Lentiviral human C5orf46 shRNA (UAS) plasmid
Sign In for Pricing
View Details 
133324-ML650 100 µL
SHIP2 (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 2, SH2 Domain-containing Inositol-5'-phosphatase 2, SH2 Domain-containing Inositol Phosphatase 2, SHIP-2, Inositol Polyphosphate Phosphatase-like Protein 1, INPPL-1, Protein 51C, INPPL1) (MaxLight 650)
Sign In for Pricing
View Details 
